Andrew P Degnan

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew D Hill, Haiquan Fang, Derek Norris, George V Delucca, Hong Huang, Mikkel DeBenedetto, Claude Quesnelle, William D Schmitz, John S Tokarski, Steven Sheriff, Chunhong Yan, Caroline Fanslau, Zuzana Haarhoff, Christine Huang, Melissa Kramer, Shilpa Madari, Krista Menard, Laura Monereau, John Morrison, Nirmala Raghavan, Eric E Shields, Jean Simmermacher-Mayer, Michael Sinz, Ching Kim Tye, Richard Westhouse, Chunshan Xie, Haiying Zhang, Lisa Zhang, Tatyana Zvyaga, Francis Lee, Ashvinikumar V Gavai, Andrew P Degnan
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties. ACS medicinal chemistry letters 13 (7) (2022)
Michael D Mandler, Andrew P Degnan, Shasha Zhang, Darpandeep Aulakh, Ketleine Georges, Bhupinder Sandhu, Amy Sarjeant, Yeheng Zhu, Sarah C Traeger, Peter T W Cheng, Bruce Alan Ellsworth, Alicia Regueiro-Ren
Structural and Thermal Characterization of Halogenated Azidopyridines: Under-Reported Synthons for Medicinal Chemistry. Organic letters (2021)

Andrew P Degnan.css-eqlu8i{font-size:small;padding-left:4px;}